Cancer drugs are in short supply, and this problem is now gripping American health care. To help, the Food and Drug Administration (FDA) is greenlighting a cancer drug from China. Some applaud the decision, while others warn that Beijing could use medicines as a weapon against the United States by withholding supplies or selling drugs that lack effective ingredients.
Topics in this episode:
- FDA Greenlights Cancer Drug from China Amid Shortage
- Sequoia Capital Separates Its U.S., China Business
- TikTok Stars’ SSN Stored in China: Report
- Sec. of State Blinken to Visit China Soon: Report
- China, Russia Launch Joint Air Patrol near Japan
- ‘Silent Barker’: U.S. Spy Satellites to Counter China, Russia
- German Pilots Pass NATO’s Tactics to China
- Russian Airspace Closure Slows Foreign Flights To, from China
- China’s Wheat Growers Face ‘Disaster’ Amid Heavy Rain
- Cybersecurity Expert on ‘Severe’ Attack on U.S. Navy by Chinese Hackers